ANI Pharmaceuticals, Inc. (ANIP)
72.17
+1.68
(+2.38%)
USD |
NASDAQ |
Mar 16, 16:00
72.17
0.00 (0.00%)
After-Hours: 20:00
ANI Pharmaceuticals Debt to Equity Ratio : 1.162 for Dec. 31, 2025
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| CorMedix, Inc. | 0.3674 |
| Castle Biosciences, Inc. | 0.0786 |
| Allogene Therapeutics, Inc. | 0.2846 |
| Catalyst Pharmaceuticals, Inc. | 0.0029 |
| Assertio Holdings, Inc. | 0.425 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.440B |
| Total Liabilities (Quarterly) | 899.65M |
| Shareholders Equity (Quarterly) | 540.72M |
| Current Ratio | 2.707 |
| Net Debt Paydown Yield | 0.25% |